Down 10% in a month with a near-7% yield — are Aviva shares the perfect ISA buy?

Harvey Jones says stock market volatility could give investors the opportunity to snap up Aviva shares at a reduced price for their Stocks and Shares ISA.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Road 2025 to 2032 new year direction concept

Image source: Getty Images

I’ve been keeping a close eye on Aviva (LSE: AV) shares. I’ve long considered it one of the most complete FTSE 100 stocks, offering both solid share price growth and a generous dividend yield.

The shares have climbed more than 50% over the past five years, while at times yielding as much as 7%-8%. That stellar rate of income comes on top of the capital growth. Unfortunately, I didn’t buy Aviva. Instead, I invested in FTSE 100 rival Legal & General Group, which is far from perfect. While it offers a hugely attractive dividend yield of around 9%, the share price has gone nowhere in the past decade. After a string of false dawns, it’s effectively ending up where it started.

Aviva is a different beast. CEO Amanda Blanc, who took over in July 2020, has led a major turnaround. She has streamlined the business, sharpened its focus and exited lower-growth, non-core operations to concentrate on its most profitable areas.

Rival FTSE 100 insurers

Aviva now offers a broad spread of insurance, wealth, and retirement services. The acquisition of Direct Line has strengthened its position in key UK markets such as motor and home insurance, reinforcing its scale and competitiveness. For a long time, I felt I had missed my chance, and was forced to comfort myself with Legal & General’s dividends. So has the recent pullback has given me a second shot?

The shares are down around 10% in the past month and roughly 10% over the past year. That’s mostly due to Iran uncertainty, coupled with a sense that the shares have run as far as they could. Dips like these can give investors a chance to buy into quality companies they previously felt were too expensive.

This morning, the FTSE 100 has jumped 1.75% on hopes of a possible peace deal involving Iran. Whether that optimism lasts is uncertain. Markets could just as easily reverse tomorrow. There is no clear resolution in sight in my view, and I think recent stock market volatility is likely to continue.

Aviva is participating in the rebound, up around 2.5% today. But its attractive valuation and high yield remain intact. The group currently trades on a forward price-to-earnings ratio of 11.9, with a forward dividend yield of 6.95%.

Strong results, plus buybacks

Aviva delivered another strong set of 2025 results on 5 March. Operating profit rose 25% to £2.3bn, and the board reinstated share buybacks with a new £350m programme. It has also set challenging medium-term targets, including 11% annualised growth in earnings per share between 2025 and 2028. Investors hoped for more, which shows how high expectations have become. But that pullback may now offer a second chance to get in.

Of course, volatility remains a risk. Given Aviva’s exposure to asset and wealth management, it will not be immune if markets weaken further or experience a broader downturn. Stock performance is cyclical, and Aviva may have gone as far as it can.

Even so, with a long-term view, I think it remains a high-quality stock worth considering today. Exactly the kind of business investors should be looking for in uncertain times. I just wish I could say the same about Legal & General.

Harvey Jones has positions in Legal & General Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »